You’ve invested billions of dollars and years of research and chemical engineering to develop a drug. Our biochemists and researchers specialize in Phase 1 safety and tolerability, MTD, PK, PD, assays and more.
Prove Patient Safety
Executing Phase II and III trials for a new drug are transformative activities for both developer and patients. Our experienced clinical trial specialists collect and determine direct data collection, reporting and management.
Plan for the future
Seeing your drug approved for marketing is really just the beginning of Phase IV, which will last for as long as your drug is on the market. Our surveillance experts know that tracking real life outcomes is the key to the future.
How We Can Help
Clinical trial data collection can be managed in many ways, even as the global marketplace becomes more digitally driven. Whether you are collecting data using fully digital methods through eCREs, ePROs, and mobile devices, or rely on hard copied patient diaries, forms, and questionnaires, we can help.
All incoming data collection forms, whether manual or digital, must be meticulously reviewed by experts in clinical trial data requirements. The credibility of your clinical trial is directly correlated to the quality of source documentation.
The Case Report Form, or CRF, is more than just a questionnaire. Your clinical study protocols should drive how your CRF is designed. The primary purpose of your clinical trial CRF is to create a standardized response form and consistency in data. Not only does a capable CRF preserve the integrity of incoming data, but it also protects and maintains quality.